As demand for GLP-1 medications continues to grow, independent pharmacies have another opportunity to demonstrate their value to patients. The new Medicare GLP-1 Bridge program that began on July 1, 2026, expands access to select weight-loss medications for eligible Medicare beneficiaries, but it also introduces new workflows that pharmacies should understand before patients begin asking questions. Read more.